Research published in October 2021 in the BMJ showed that Molnupiravir reduced the risk of hospitalization by 50% in people at higher risk of severe COVID-19. While COVID-19 vaccines have been crucial in helping reduce the number of fatalities caused by SARS-CoV-2 infections, antivirals also played a part. One of those drugs is molnupiravir, which the Food & […]
